Olympus is once again embroiled in controversy following the discovery of emails that show the company pushed up the price of duodenoscopes after the deadly Carbapenem-resistant Enterobacteria outbreak at UCLA’s Ronald Reagan Medical Center, which left three dead.
Olympus unveiled the VISERA 4K UHD System.
Cairn Diagnostics launched the 13C-Spirulina Gastric Emptying Breath Test.
Zacks Investment Research upgraded EndoChoice Holdings from a “hold” rating to a “buy” rating.
Zydus Healthcare, a subsidiary of Cadila Healthcare, acquired gastrointestinal brand ‘Actibile’ from drug firm Albert David.
R. Gregory Scheible, MD, is the first physician Indiana to implant Apollo Endosurgery’s Orbera intragastric balloon in a patient using a non-surgical procedure.
Clinical Genomics recently closed a $15 million series A financing round.
GI Dynamics appointed Scott Schorer as president and CEO, effective immediately.
More articles on GI/endoscopy:
5 most read GI/endoscopy stories
What ulcerative colitis patients most want to know from their physicians
GI Dynamics names Scott Schorer CEO
